Additional information
| Active substance | Pregabalin |
|---|---|
| Chemical name | (3S)-3-(aminomethyl)-5-methylhexanoic acid |
| Side effects | Dizziness, sleepiness, dry mouth, and blurred vision |
| Effects | Analgesic, anticonvulsant, and anxiolytic effects |
| Dosage (sports) | Not applicable as it is not typically used for performance enhancement |
| Dosage (medical) | Typically starts at 150 mg per day, divided into 2-3 doses, and can be increased to a maximum of 600 mg per day |
| Half-life | 6.3 hours |
| Main action | Reduces the release of several neurotransmitters, including glutamate, norepinephrine, and substance P |
| Substance class | Gabapentinoid |
| Formula | C8H17NO2 |
| Storage conditions | Store at room temperature away from light and moisture |
| Trade name | Lyrica |
| Blood pressure | Typically has minimal impact on blood pressure |
| WAREHOUSE | International Warehouse 1 |
| Also known as | Lyrica |
| Lab Test | Detection involves specific analytical techniques like gas chromatography-mass spectrometry (GC-MS) |
| Hepatotoxicity | Low |
| Water Retention | Minimal |
| Classification | Anticonvulsants |
| Use in sports | Not commonly used in sports, lacks performance-enhancing properties |
| Manufacturer | Signature |
Reviews
There are no reviews yet.